株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

体外診断(IVD)の世界市場の分析 - 製品(医療機器、試薬、キット、サービス)、技術、用途、エンドユーザー、地域別の市場機会と予測(2014年~2024年)

Global In Vitro Diagnostics (IVD) Market: Analysis By Product (Medical Devices, Reagents and Kits, Services), By Technology, Application, End User, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)

発行 Azoth Analytics 商品コード 920040
出版日 ページ情報 英文 270 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.07円で換算しております。
体外診断(IVD)の世界市場の分析 - 製品(医療機器、試薬、キット、サービス)、技術、用途、エンドユーザー、地域別の市場機会と予測(2014年~2024年) Global In Vitro Diagnostics (IVD) Market: Analysis By Product (Medical Devices, Reagents and Kits, Services), By Technology, Application, End User, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)
出版日: 2019年12月31日 ページ情報: 英文 270 Pages
概要

当レポートでは、世界の体外診断(IVD)市場を調査し、市場の概要、製品・技術・用途・エンドユーザー・地域別の市場規模の推移と予測(通算11年間分)、市場動向、市場の成長要因および課題の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 レポート範囲と調査方法

  • レポート範囲
  • 調査手法
  • エグゼクティブサマリー

第2章 戦略提言

第3章 体外診断製品の概要

第4章 世界の体外診断(IVD)市場の分析

第5章 世界の体外診断(IVD)市場:技術別

  • 競合シナリオ:技術別
  • 集中治療・ポイントオブケア
  • 糖尿病治療
  • 分子診断
  • 組織診断

第6章 世界の体外診断(IVD)市場:用途別

  • 競合シナリオ:用途別
  • 感染症
  • 非感染症

第7章 世界の体外診断(IVD)市場:エンドユーザー別

  • 競合シナリオ:エンドユーザー別
  • 病院
  • 研究所
  • 在宅検査
  • その他

第8章 世界の体外診断(IVD)市場:製品別

  • 競合シナリオ:製品別
  • 医療機器
  • 試薬・キット
  • サービス

第9章 世界の体外診断(IVD)市場:地域別

  • 競合シナリオ:地域別

第10章 北米の体外診断(IVD)市場:セグメント別

  • 市場規模(実績値・予測値)
  • 主要企業
  • 市場区分:技術別
  • 市場区分:用途別
  • 市場区分:エンドユーザー別
  • 市場区分:製品別
  • 市場区分:国別
  • 競合シナリオ:国別
  • 米国
  • カナダ
  • その他

第11章 ラテンアメリカの体外診断(IVD)市場:セグメント別

  • 市場規模(実績値・予測値)
  • 主要企業
  • 市場区分:技術別
  • 市場区分:用途別
  • 市場区分:エンドユーザー別
  • 市場区分:製品別
  • 市場区分:国別
  • 競合シナリオ:国別
  • ブラジル
  • メキシコ
  • その他

第12章 アジア太平洋地域の体外診断(IVD)市場:セグメント別

  • 市場規模(実績値・予測値)
  • 主要企業
  • 市場区分:技術別
  • 市場区分:用途別
  • 市場区分:エンドユーザー別
  • 市場区分:製品別
  • 市場区分:国別
  • 競合シナリオ:国別
  • 中国
  • 日本
  • インド
  • その他

第13章 欧州・中東・アフリカの体外診断(IVD)市場:セグメント別

  • 市場規模(実績値・予測値)
  • 主要企業
  • 市場区分:技術別
  • 市場区分:用途別
  • 市場区分:エンドユーザー別
  • 市場区分:製品別
  • 市場区分:国別
  • 競合シナリオ:国別
  • ドイツ
  • イタリア
  • 英国
  • その他

第14章 市場力学

  • 成長要因
  • 阻害要因
  • 市場動向

第15章 戦略分析と市場魅力度

  • 市場魅力度:セグメント別
  • 戦略分析

第16章 競合情勢

  • 市場シェア分析
  • 企業の市場ポジショニング
  • SWOT分析
  • ファイブフォース分析

第17章 企業プロファイル

  • F .Hoffman-La Roche AG
  • Thermo Fisher Scientific
  • Sysmex
  • Abbott
  • Danaher
  • Siemens Healthineers
  • Biomerieux
  • Bio- Rad Laboratories
  • Becton Dickinson
  • Ortho Clinical Diagnostics
図表

List of Figures

  • Figure 1: Global In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 2: Life expectancy above 65 years of age, year-2017
  • Figure 3: Deaths due to communicable, Maternal, Neonatal disorders and Nutritional Deficiencies(%), Year-2017
  • Figure 4: Global, Diabetics Incidence Rates, 2013-2017, Per 100000
  • Figure 5: Global Market share By technology 2018 & 2024
  • Figure 6: Global In Vitro Diagnostics Market- By Centralised and point of care, By Value (USD Million), 2014-2024
  • Figure 7: Global In Vitro Diagnostics Market- By Diabetes Care, By Value (USD Million), 2014-2024
  • Figure 8: Global In Vitro Diagnostics Market- By Molecular Diagnostics, By Value (USD Million), 2014-2024
  • Figure 9: Global In Vitro Diagnostics Market- By Tissue Diagnostics, By Value (USD Million), 2014-2024
  • Figure 10: Global Market Share by Application 2018 & 2024
  • Figure 11: Global In Vitro Diagnostics Market- By Non Infectious Disease, By Value (USD Million), 2014-2024
  • Figure 12: Global In Vitro Diagnostics Market- By Infectious Disease, By Value (USD Million), 2014-2024
  • Figure 13: Global Market Share By End User 2018 & 2024
  • Figure 14: Global In Vitro Diagnostics Market- By Hospitals, By Value (USD Million), 2014-2024
  • Figure 15: Global In Vitro Diagnostics Market- By Laboratory, By Value (USD Million), 2014-2024
  • Figure 16: Global In Vitro Diagnostics Market- By Home Test, By Value (USD Million), 2014-2024
  • Figure 17: Global In Vitro Diagnostics Market- By Others, By Value (USD Million), 2014-2024
  • Figure 18: Global Market Share By Products 2018 & 2024
  • Figure 19: Global In Vitro Diagnostics Market- By Medical Devices, By Value (USD Million), 2014-2024
  • Figure 20: Global In Vitro Diagnostics Market- By Reagents and Kits, By Value (USD Million), 2014-2024
  • Figure 21: Global In Vitro Diagnostics Market- By Services, By Value (USD Million), 2014-2024
  • Figure 22: Global Market Share by Region 2018 & 2024
  • Figure 23: North America in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 24: North America population aged 65 and above, 2013-2016 (% of total)
  • Figure 25: North America GDP per Capita, 2014-2017 (USD)
  • Figure 26: North America Healthcare Cost Per Capita, 2018 (USD)
  • Figure 27: North America Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
  • Figure 28: North America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 29: North America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 30: North America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 31: North America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 32: Market Opportunity Chart of North America In Vitro Diagnostics Market - By Country, By Value (Year-2024)
  • Figure 33: North America IVD, By Country, Year 2018 & 2024
  • Figure 34: United States In vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 35: United States population aged 65 and above, 2014- 2018(% of total)
  • Figure 36: United States GDP per Capita, 2013-2017 (USD) (In Trillion)
  • Figure 37: United States Healthcare Cost Per Capita, 2013-2017(USD)
  • Figure 38: United States Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
  • Figure 39: United States In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 40: Uniited States In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 41: United States In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 42: United States In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 43: Canada In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 44: Canada population aged 65 and above, 2014-2018 (% of total)
  • Figure 45: Canada GDP , 2013-2017 (USD) (In Trillion)
  • Figure 46: Canada Healthcare Cost Per Capita, 2013-2017 (%)
  • Figure 47: Canada Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
  • Figure 48: Canada In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 49: Canada In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 50: Canada In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 51: Canada In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 52: Rest of North America In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 53: Rest of North America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 54: Rest of North America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 55: Rest of North America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 56: Rest of North America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 57: Latin America in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 58: Latin America population aged 65 and above, 2013-2018 (% of total)
  • Figure 59: Latin America GDP, 2013-2017 (USD)(In Trillion)
  • Figure 60: Latin America Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
  • Figure 61: Latin America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 62: Latin America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 63: Latin America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 64: Latin America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 65: Market Opportunity Chart of Latin America In Vitro Diagnostics Market - By Country, By Value (Year-2024)
  • Figure 66: Latin America IVD, By Country, Year 2018 & 2024
  • Figure 67: Brazil In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 68: Brazil population aged 65 and above, 2014-2018(%of total)
  • Figure 69: Brazil GDP , 2013-2017 (USD) (In Trillion)
  • Figure 70: Brazil Healthcare Cost Per Capita, 2013-2016(%)(Expected)
  • Figure 71: Brazil Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
  • Figure 72: Brazil In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 73: Brazil In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 74: Brazil In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 75: Brazil In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 76: Mexico In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 77: Mexico population aged 65 and above, 2014-2018 (% of total)
  • Figure 78: Mexico GDP , 2013-2017 (USD) (In Trillion)
  • Figure 79: Mexico Healthcare Cost Per Capita, 2013-2017 (%)
  • Figure 80: Mexico Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
  • Figure 81: Mexico In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 82: Mexico In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 83: Mexico In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 84: Mexico In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 85: Rest of Latin America In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 86: Rest of Latin America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 87: Rest of Latin America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 88: Rest of Latin America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 89: Rest of Latin America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 90: Asia Pacific in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 91: Asia Pacific population aged 65 and above, 2014-2018 (% of total)
  • Figure 92: East Asia & Pacific GDP , 2013-2017 (USD) (In Trillion)
  • Figure 93: Asia Pacific Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
  • Figure 94: Asia Pacific In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 95: Asia Pacific In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 96: Asia Pacific In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 97: Asia Pacific In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 98: Market Opportunity Chart of Asia Pacific In Vitro Diagnostics Market - By Country, By Value (Year-2024)
  • Figure 99: Asia Pacific IVD, By Country, Year 2018 & 2024
  • Figure 100: Japan In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 101: Japan population aged 65 and above, 2014-2018 (% of total)
  • Figure 102: Japan GDP , 2013-2017 (USD) (In Trillion)
  • Figure 103: Japan Healthcare Cost Per Capita, 2013-2017 (%)
  • Figure 104: Japan Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
  • Figure 105: Japan In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 106: Japan In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 107: Japan In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 108: Japan In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 109: China In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 110: China population aged 65 and above, 2014-2018 (% of total)
  • Figure 111: China GDP, 2013-2017 (USD) (In Trillion)
  • Figure 112: China Healthcare Cost Per Capita, 2013-2016 (%)
  • Figure 113: China Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
  • Figure 114: China In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 115: China In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 116: China In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 117: China In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 118: India In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 119: India population aged 65 and above, 2014-2018 (% of total)
  • Figure 120: India GDP, 2013-2017 (USD) (In Trillion)
  • Figure 121: India Healthcare Cost Per Capita, 2013-2016 (%)
  • Figure 122: India Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
  • Figure 123: India In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 124: India In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 125: India In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 126: India In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 127: Rest of Asia Pacific In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 128: Rest of Asia Pacific In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 129: Rest of Asia Pacific In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 130: Rest of Asia Pacific In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 131: Rest of Asia Pacific In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 132: Europe, Middle East and Africa in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD
  • Figure 133: European Union and North Africa Middle East population aged 65 and above, 2014-2018 (% of total)
  • Figure 134: European Union and North Africa Middle East,GDP , 2013-2017 (USD) (In Trillion)
  • Figure 135: European Union and North Africa Middle East, Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
  • Figure 136: EMEA In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 137: EMEA In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 138: EMEA In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 139: EMEA In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 140: Market Opportunity Chart of EMEA In Vitro Diagnostics Market - By Country, By Value (Year-2024)
  • Figure 141: EMEA IVD, By Country, Year 2018 & 2024
  • Figure 142: Germany In Vitro Diagnostic Market Size By value,2014-2024(USD Million)
  • Figure 143: Germany population aged 65 and above,2014-2018(% of total)
  • Figure 144: Germany GDP,2013-2017(USD) (In Trillion)
  • Figure 145: Germany Healthcare cost per capita,2014-2018(%)
  • Figure 146: Germany death by liver cancer, 2014-2017(per 100k individuals)
  • Figure 147: Germany In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 148: Germany In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 149: Germany In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 150: Germany In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 151: Italy In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 152: Italy population aged 65 and above, 2014-2018 (% of total)
  • Figure 153: Italy GDP, 2013-2017 (USD) (In Trillion)
  • Figure 154: Italy Healthcare Cost Per Capita, 2014-2018 (%)
  • Figure 155: Italy Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
  • Figure 156: Italy In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 157: Italy In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 158: Italy In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 159: Italy In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 160: UK In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 161: UK population aged 65 and above, 2014-2018 (% of total)
  • Figure 162: UK GDP, 2013-2017 (USD) (In Trillion)
  • Figure 163: UK Healthcare Cost Per Capita, 2014-2018 (%)
  • Figure 164: UK Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
  • Figure 165: United Kingdom In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 166: UK In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 167: UK In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 168: UK In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 169: Rest of EMEA In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
  • Figure 170: Rest of EMEA In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
  • Figure 171: Rest of EMEA In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
  • Figure 172: Rest of EMEA In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
  • Figure 173: Rest of EMEA In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
  • Figure 174: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Technology (Year-2024)
  • Figure 175: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Application (Year-2024)
  • Figure 176: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By End User(Year-2024)
  • Figure 177: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Products (Year-2024)
  • Figure 178: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Region (Year-2024)
  • Figure 179: Competitive Positions of In Vitro Diagnostics Companies (2018)
  • Figure 180: F.Hoffman-La Roche, Diagnostics Sales Revenue, 2014-2018 (USD Million)
  • Figure 181: F.Hoffman-La Roche, Sales Revenue, By Region, In 2018 (%)
  • Figure 182: F.Hoffman-La Roche Net Income, Year 2014-2018 (USD MILLION)
  • Figure 183: F.Hoffman-La Roche, Diagnostics Division Business Area Sales Revenue, 2018 ,(USD Million)
  • Figure 184: F.Hoffman-La Roche , E7 Leading Emerging Market Sales Revenue, By Region, In 2018 (%)
  • Figure 185: Thermo Fisher Scientific, Sales Revenue, 2014-2018 (USD Million)
  • Figure 186: Thermo Fisher Scientific, Net Income, 2014-2018 (USD Million)
  • Figure 187: Thermo Fisher Scientific, Sales Revenue, By Business Segment, In 2018 (%)
  • Figure 188: Thermo Fisher Scientific, Sales Revenue, By Geographical Segment, In 2018 (%)
  • Figure 189: Sysmex, Sales Revenue, 2014-15 to 2018-2019 (USD Million)
  • Figure 190: Sysmex, Net Income, 2014-2018 (USD Million)
  • Figure 191: Sysmex, Sales Revenue, By Geographical Segment, In 2018 (%)
  • Figure 192: Abbott, Total Sales Revenue, 2014-2018 (USD Million)
  • Figure 193: Abbott, Net Income, 2014-2018 (USD Million)
  • Figure 194: Abbott, Sales Revenue, By Geographical Segment, In 2018 (%)
  • Figure 195: Abbott, Diagnostics Sales Revenue, 2014-2018 (USD Million)
  • Figure 196: Abbott, Diagnostics specific Business Division Sales Revenue, , In 2018 (USD Million)
  • Figure 197: Danaher, Total Sales Revenue, 2014-2018 (USD Million)
  • Figure 198: Danaher, Net Income, 2014-2018 (USD Million)
  • Figure 199: Danaher, Total Sales ,By Business Segments,2018 (USD Million)
  • Figure 200: Danaher, Sales Revenue ,Diagnostics Segment, By Geographical Segment, In 2018 (%)
  • Figure 201: Siemens Healthineers , Total Sales Revenue, 2017-2018 (USD Million)
  • Figure 202: Siemens Healthineers, Net Income, 2017-2018 (USD Million)
  • Figure 203: Siemens Healthineers Sales Revenue , By Geographical Segment, In 2018 (%)
  • Figure 204: Siemens Healthineers , Sales Revenue, By Segments,2018 (USD Million)
  • Figure 205: Siemens Healthineers Revenue By Segment, In 2018 (%) (in Billion)
  • Figure 206: Biomerieux , Total Sales Revenue, 2014-2018 (USD Million)
  • Figure 207: Biomerieux, Net Income, 2014-2018 (USD Million)
  • Figure 208: Biomerieux Sales Revenue , By Geographical Segment, In 2018 (%)
  • Figure 209: Biomerieux , Sales By Application, 2018 (%)
  • Figure 210: Bio-Rad Laboratories Sales Revenue, 2014-2018 (USD Million)
  • Figure 211: Bio-Rad Laboratories ,Business Segment wise sales FY- 2016-2018 ,(USD millions)
  • Figure 212: Bio-Rad Laboratories Sales Revenue, By Geographic Segment (%), FY2018
  • Figure 213: Bio-Rad, Net Income, 2014-2018 (USD Million)
  • Figure 214: Becton Dickinson Sales Revenue, 2013-2014 to 2017-2018 (USD Million)
  • Figure 215: Becton Dickinson , Total Business Segment Revenue FY- 2018 ,(USD millions)
  • Figure 216: Becton Dickinson Geographic Sales Revenue,2018 (USD Million)
  • Figure 217: Becton Dickinson, Net Income, 2014-2018 (USD Million)
  • Figure 218: Becton Dickinson, Life Sciences Business Segment Revenue 2018 ,(USD millions)

List Of Table

Table A: List of some FDA approved In Vitro Diagnostic Products

Table B: General IVDs for use in community settings and health facilities without laboratories

Table C: Health care facilities with clinical laboratories

Table D: Prominent In Vitro Diagnostics companies operating in North America Market

Table E: Prominent In Vitro Diagnostics companies operating in Latin America Market

Table F: Prominent In Vitro Diagnostics companies operating in Asia Pacific Market

Table G: Prominent In Vitro Diagnostics companies operating in EMEA Market

Table H: GlobalMarket share analysis of In Vitro Dignostic Companies

目次

Executive Summary

Global In Vitro Diagnostics Market was valued at USD 61700.22 Million in the year 2018. As size of old age population is increasing globally, quality healthcare is required. Diagnostics have major role, as majority of clinical decisions are based on diagnostic test result. They assist in providing personalised treatment and drugs are administered to the patient specifically. Additionally, number of patients suffering from chronic and infectious disease are increasing globally, which is primarily powered by unhealthy lifestyle, air and water pollution, genetic modification of disease causing microbes, which is estimated to accelerate the In Vitro Diagnostics Market Growth during the period of 2019-2024.

Molecular Diagnostics technology has been estimated to propel the market growth globally mainly because of large number of chronic diseases such as cancer, genetic disease, Non Invasive Prenatal Testing. Also, End User growth rate of home test kits will be high due to ease of testing, cost effectiveness and accuracy of test results obtained. By product type, reagents and kits will have high growth rate, as they get consumed in the diagnostic process and have to be replenished. Also rising investment by leading IVD companies in development and automation of IVD products, according to disease specificity, has been anticipated to spur the market growth during the forecast period.

Scope of the Report

Global In Vitro Diagnostics Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • In Vitro Diagnostics Market - Size, Growth, Forecast
  • Analysis By Technology: Centralised and Point of care, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics
  • Analysis By Application: Infectious Disease, Non Infectious Disease
  • Analysis By End User: Hospital, Laboratory, Home Test, Others
  • Analysis By Product- Medical Devices, Reagents & Kits, Services

Regional Analysis - North America, Latin America, Asia Pacific, EMEA (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • In Vitro Diagnostics Market - Size, Growth, Forecast
  • Analysis By Technology: Centralised and Point of care, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics
  • Analysis By Application: Infectious Disease, Non Infectious Disease
  • Analysis By End User: Hospital, Laboratory, Home Test, Others
  • Analysis By Product- Medical Devices, Reagents & Kits, Services

Country Analysis - USA, Canada, Germany, UK, Italy, Japan, China, India, Brazil, Mexico (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • In Vitro Diagnostics Market - Size, Growth, Forecast
  • Analysis By Technology: Centralised and Point of care, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics
  • Analysis By Application: Infectious Disease, Non Infectious Disease
  • Analysis By End User: Hospital, Laboratory, Home Test, Others
  • Analysis By Product- Medical Devices, Reagents & Kits, Services

Other Report Highlights

  • Competitive Landscape
  • Leading Companies
  • Key Developments
  • Market Dynamics - Drivers and Restraints.
  • Market Trends
  • SWOT Analysis.
  • Company Analysis - Roche, Sysmex, Abbott, Danaher, Siemens Healthineers, Biomerieux, Becton-Dickinson, Thermofisher Scientific, Bio-Rad, Ortho clinical Diagnostics.

Customization of the Report

The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

Table of Contents

1. Report scope & Methodology

  • 1.1 Scope of the Report
  • 1.2 Research Methodology
  • 1.3 Executive Summary

2. Strategic Recommendations

  • 2.1 Focus on Theranostics
  • 2.2 Investment in Microbiology system automation
  • 2.3 Reducing the cost of diagnostic test

3. Global IVD Market: Product Outlook

4. Global In Vitro Diagnostics Market: An Analysis

  • 4.1 Market Size, By Value, Year 2014-2024

5. Global In Vitro Diagnostics Segmentation By Technology (By Value)

  • 5.1 Competitive Scenario of In Vitro Diagnostics: By Technology
  • 5.2 Centralised and Point of Care - Market Size and Forecast (2019-2024)
  • 5.3 Diabetes Care - Market Size and Forecast (2019-2024)
  • 5.4 Molecular Diagnostics - Market Size and Forecast (2019-2024)
  • 5.5 Tissue Diagnostics - Market Size and Forecast (2019-2024)

6. Global In Vitro Diagnostics Market Segmentation By Application (By Value)

  • 6.1 Competitive Scenario of Global In Vitro Diagnostics: By Application
  • 6.2 Infectious Disease - Market Size and Forecast (2019-2024)
  • 6.3 Non Infectious Disease- Market Size and Forecast (2019-2024)

7.Global In Vitro Diagnostics Segmentation By End User (By Value)

  • 7.1 Competitive Scenario of Global In Vitro Diagnostics: By End User
  • 7.2 Hospitals - Market Size and Forecast (2019-2024)
  • 7.3 Laboratory - Market Size and Forecast (2019-2024)
  • 7.4 Home Test - Market Size and Forecast (2019-2024)
  • 7.5 Others - Market Size and Forecast (2019-2024

8. Global In Vitro Diagnostics Segmentation By Products (By Value)

  • 8.1 Competitive Scenario of Global In Vitro Diagnostics: By Products
  • 8.2 Medical Devices - Market Size and Forecast (2019-2024)
  • 8.3 Reagents and Kits - Market Size and Forecast (2019-2024)
  • 8.4 Services - Market Size and Forecast (2019-2024)

9. Global In Vitro Diagnostics: Regional Analysis

  • 9.1 Competitive Scenario of Global In Vitro Diagnostics: By Region

10. North America In Vitro Diagnostics Market: Segmentation By Technology, Application, End User, Products (2019-2024)

  • 10.1 North America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 10.2 North America In Vitro Diagnostics Market - Prominent Companies
  • 10.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
  • 10.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
  • 10.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
  • 10.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)
  • 10.7 North America In Vitro Diagnostics Market: Country Analysis
  • 10.8 Market Opportunity Chart of North America In Vitro Diagnostics Market- By Country, By Value (Year-2024)
  • 10.9 Competitive Scenario of North America In Vitro Diagnostics : By Country
  • 10.10 United States In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 10.11 United States In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
  • 10.12 Canada In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 10.13 Canada In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
  • 10.14 Rest of North America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 10.15 Rest of North America In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)

11. Latin America In Vitro Diagnostics Market: Segmentation By Technology, Application, End User, Products (2019-2024)

  • 11.1 Latin America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 11.2 Latin America In Vitro Diagnostics Market - Prominent Companies
  • 11.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
  • 11.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
  • 11.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
  • 11.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)
  • 11.7 Latin America In Vitro Diagnostics Market: Country Analysis
  • 11.8 Market Opportunity Chart of Latin America In Vitro Diagnostics Market- By Country, By Value (Year-2024)
  • 11.9 Competitive Scenario of Latin America In Vitro Diagnostics: By Country
  • 11.10 Brazil In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 11.11 Brazil In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
  • 11.12 Mexico In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 11.13 Mexico In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
  • 11.14 Rest of Latin America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 11.15 Rest of Latin America In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)

12.Asia Pacific In Vitro Diagnostics Market: Segmentation By Technology, Application, End User, Products (2019-2024)

  • 12.1 Asia Pacific In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 12.2 Asia Pacific In Vitro Diagnostics Market - Prominent Companies
  • 12.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
  • 12.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
  • 12.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
  • 12.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)
  • 12.7 Asia Pacific In Vitro Diagnostics Market: Country Analysis
  • 12.8 Market Opportunity Chart of Asia Pacific In Vitro Diagnostics Market- By Country, By Value (Year-2024)
  • 12.9 Competitive Scenario of Asia Pacific In Vitro Diagnostics : By Country
  • 12.10 Japan In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 12.11 Japan In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
  • 12.12 China In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 12.13 China In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
  • 12.14 India In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 12.15 India In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
  • 12.16 Rest of Asia Pacific In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 12.17 Rest of Asia Pacific In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)

13. EMEA In Vitro Diagnostics Market: Segmentation By Technology, Application, End User, Products (2019-2024)

  • 13.1 EMEA In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 13.2 EMEA In Vitro Diagnostics Market - Prominent Companies
  • 13.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
  • 13.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
  • 13.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
  • 13.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)
  • 13.7 EMEA In Vitro Diagnostics Market: Country Analysis
  • 13.8 Market Opportunity Chart of EMEA In Vitro Diagnostics Market- By Country, By Value (Year-2024)
  • 13.9 Competitive Scenario of EMEA In Vitro Diagnostics : By Country
  • 13.10 Germany In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 13.11 Germany In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
  • 13.12 Italy In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 13.13 Italy In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
  • 13.14 United Kingdom In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 13.15 United Kingdom In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
  • 13.14 Rest of EMEA In Vitro Diagnostics Market: Size and Forecast (2019-2024)
  • 13.15 Rest of EMEA In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)

14. Global In Vitro Diagnostics Market Dynamics

  • 14.1 Global In Vitro diagnostic Market Drivers
  • 14.2 Global In Vitro Diagnostic Market Restraints
  • 14.3 Global In Vitro Diagnostic Market Trends

15. Market Attractiveness and Strategic Analysis

  • 15.1 Market Attractiveness
    • 15.1.1 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Technology (Year 2024)
    • 15.1.2 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Application (Year 2024)
    • 15.1.3 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By End User (Year 2024)
    • 15.1.4 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Products (Year 2024)
    • 15.1.5 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Region (Year 2024)
  • 15.2 Strategic Analysis
    • 15.2.1 New Product Development
    • 15.2.2 Key Developments in In Vitro Diagnostics Market

16. Competitive Landscape

  • 16.1 Market Share Analysis
  • 16.2 Competitive Positioning (Leaders, Challengers, Followers, Niche Players)
  • 16.3 SWOT Analysis
  • 16.4 Porter's Five Force Analysis

17. Company Analysis (Business Description, Financial Analysis, Business Strategy)

  • 17.1 F .Hoffman-La Roche AG
  • 17.2 Thermo Fisher Scientific
  • 17.3 Sysmex
  • 17.4 Abbott
  • 17.5 Danaher
  • 17.6 Siemens Healthineers
  • 17.7 Biomerieux
  • 17.8 Bio- Rad Laboratories
  • 17.9 Becton Dickinson
  • 17.10 Ortho Clinical Diagnostics